SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 60 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $2,000 | -66.7% | 2,903 | -58.6% | 0.00% | -100.0% |
| Q4 2015 | $6,000 | – | 7,006 | +6906.0% | 0.00% | – |
| Q2 2015 | $0 | -100.0% | 100 | -95.3% | 0.00% | -100.0% |
| Q1 2015 | $5,000 | -72.2% | 2,131 | -14.2% | 0.00% | -50.0% |
| Q3 2014 | $18,000 | – | 2,484 | +7662.5% | 0.00% | – |
| Q2 2014 | $0 | -100.0% | 32 | -96.9% | 0.00% | -100.0% |
| Q1 2014 | $7,000 | +250.0% | 1,017 | +154.2% | 0.00% | – |
| Q4 2013 | $2,000 | -75.0% | 400 | -75.9% | 0.00% | -100.0% |
| Q3 2013 | $8,000 | +60.0% | 1,657 | +67.7% | 0.00% | – |
| Q2 2013 | $5,000 | – | 988 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lamond Capital Partners LLC | 1,320,000 | $9,425,000 | 10.46% |
| RA Capital Management | 4,869,261 | $34,767,000 | 4.11% |
| GREAT POINT PARTNERS LLC | 400,000 | $2,856,000 | 1.23% |
| Healthcare Value Capital, LLC | 100,000 | $714,000 | 0.69% |
| DSC Advisors, L.P. | 175,000 | $1,250,000 | 0.63% |
| Quantitative Systematic Strategies LLC | 107,416 | $803,000 | 0.47% |
| Visium Asset Management, LP | 4,093,890 | $29,230,000 | 0.43% |
| Rhenman & Partners Asset Management AB | 201,171 | $1,436,000 | 0.42% |
| EAM Investors, LLC | 277,807 | $1,984,000 | 0.40% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 354,861 | $2,534,000 | 0.39% |